Ocuphire Pharma Inc. buy BiotechBee
Start price
03.09.23
/
50%
€3.71
Target price
30.11.25
€5.00
Performance (%)
-69.50%
Price
29.08.24
€1.13
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Ocuphire Pharma Inc. is performing very badly with a performance of -69.50%. This prediction currently runs until 30.11.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ocuphire Pharma Inc. | -4.399% | -4.399% |
iShares Core DAX® | 2.147% | 2.681% |
iShares Nasdaq 100 | -0.578% | -0.816% |
iShares Nikkei 225® | 0.635% | 3.079% |
iShares S&P 500 | 0.746% | 0.171% |
According to BiotechBee what are the pros and cons of Ocuphire Pharma Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
Buy mit Kursziel 5,0
Stopped prediction by BiotechBee for Ocuphire Pharma Inc.
Ocuphire Pharma Inc.
Start price
Target price
Perf. (%)
€3.20
10.01.23
10.01.23
€6.00
31.12.25
31.12.25
-28.13%
26.01.23
26.01.23
Could be very worthwhile Investment >20% year
Ocuphire Pharma Inc.
Start price
Target price
Perf. (%)
€3.31
03.01.23
03.01.23
€5.00
31.03.25
31.03.25
-3.24%
10.01.23
10.01.23
Could be very worthwhile Investment >20% year